ENVALITH
ステラケミファ株式会社 logo

STELLA CHEMIFA CORPORATION

4109Prime MarketChemicals

ステラケミファ株式会社 logo
STELLA CHEMIFA CORPORATION4109
Reference Indicators

Market Cap

717¥100M

P/E (Forecast)

19.9x

P/B

1.4x

Dividend Yield (Forecast)

3.25%

ROE

6.6%

EV/EBITDA

8.3x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
37,29635,38230,44636,28836,799
Cost of Sales
28,39427,97223,99928,03128,218
Gross Profit
8,9027,4106,4468,2578,581
SG&A Expenses
4,3183,8963,7243,9183,936
Operating Income
4,5833,5142,7224,3384,644
Non-operating Income
1,2401,008683316244
Non-operating Expenses
116175341493464
Ordinary Income
5,7074,3473,0644,1614,424
Extraordinary Income
1,2031,40117027021
Extraordinary Losses
702,38262120750
Pre-tax Income
6,8403,3662,6134,2244,395
Income Taxes
1,8141,3837771,3521,348
Net Income
5,3642,2801,8452,8923,058
EBITDA
7,2966,1075,4907,1507,533
Gross Margin
23.9%20.9%21.2%22.8%23.3%
Operating Margin
12.3%9.9%8.9%12.0%12.6%
ROA
9.5%4.1%3.1%4.8%4.8%
ROE
13.7%5.4%4.2%6.5%6.6%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
高純度薬品31,7863,59211.3%
運輸4,8921,04521.4%
その他1202823.3%